CD123+CLL-1 CAR-T
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CD123+CLL-1 CAR-T, covering 2025-10-01 to 2025-10-01. Get the full timeline:
Most recent: Clinical Trial Update: CD123+CLL-1 CAR-T Sequential Infusion With CD7 CAR-T and Bridging to Allo-HSCT for Relapsed/Refractory Acute Myeloid Leukemia [EARLY_Phase 1]